Published in Women's Health Weekly, December 16th, 1996
The FemPatch, developed by the Parke-Davis subsidiary of Morris Plains-based Warner-Lambert Co., joins at least four estrogen patches already available commercially. The FemPatch has a lower dose of the drug estradiol than the other estrogen patches.
"There are several reasons women do not take or discontinue hormone replacement therapy," primarily the side effects,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly